Category: Zacks Small Cap Research
By Ann Heffron, CFA, CPA OTC:CPKF READ THE FULL CPKF RESEARCH REPORT CPKF’s (OTC:CPKF) third quarter net earnings increased $0.4 million, or 11%, year over year to $3.8 million, while 2021’s third quarter diluted EPS soared by $0.09, or 13%, to $0.78 ...
By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Business Update MN-166 in Combination with PD-1 Inhibitor Extends Survival in Preclinical Model On November 22, 2021, MediciNova, Inc. (NASDAQ:MNOV) announced results from a preclinic ...
By Lisa Thompson NASDAQ:DUO READ THE FULL DUO RESEARCH REPORT Fangdd (NASDAQ:DUO) is a residential real estate transaction platform company operating in China. It was founded by experienced real estate brokers to serve the needs of small and medium a ...
By Lisa Thompson NASDAQ:RCRT READ THE FULL RCRT RESEARCH REPORT We are initiating coverage of Recruiter.com (NASDAQ:RCRT). Recruiter.com, headquartered in NYC, provides a platform for companies to hire recruiters on a temporary gig or project basis ( ...
By David Bautz, PhD NASDAQ:QLGN READ THE FULL QLGN RESEARCH REPORT Financial Update On November 15, 2021, Qualigen Therapeutics, Inc. (NASDAQ:QLGN) announced financial results for the third quarter of 2021. The company reported $1.2 million in revenu ...
By M. Marin NASDAQ:ELYS READ THE FULL ELYS RESEARCH REPORT Enhancing financial flexibility to support growth initiatives Elys Game Technology (NASDAQ:ELYS) is positioning itself to advance its growth strategy and enhance its financial flexibility to ...
By David Bautz, PhD NASDAQ:EPIX READ THE FULL EPIX RESEARCH REPORT Business Update Update on Phase 1 Trial of EPI-7386 ESSA Pharma Inc. (NASDAQ:EPIX) is currently conducting a Phase 1 clinical trial of EPI-7386 in patients with metastatic castration- ...
By Steven Ralston, CFA OTC:DYLLF | ASX:DYL.AX READ THE FULL DYLLF RESEARCH REPORT Management’s goal is develop Deep Yellow (OTC:DYLLF) (ASX:DYL.AX) into a Tier I, multi-jurisdictional uranium producer during the current uranium up-cycle. Currently, ...
By Steven Ralston, CFA OTC:DYLLF | ASX:DYL.AX READ THE FULL DYLLF RESEARCH REPORT Management’s goal is develop Deep Yellow (OTC:DYLLF) (ASX:DYL.AX) into a Tier I, multi-jurisdictional uranium producer during the current uranium up-cycle. Currently, ...
By Steven Ralston, CFA NYSE:VNRX READ THE FULL VNRX RESEARCH REPORT VolitionRx (NYSE:VNRX) is engaged in multiple epigenetic projects based on company’s proprietary Nu.QTM platform, which encompasses numerous blood-based clinical assays that have bee ...